ReviewInternational journal of biomaterials2025
Metallic Nanoparticles Applications in Neurological Disorders: A Review.
Review in International journal of biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Bridging the Gap: Harnessing Phytochemical-Loaded Nanocarriers for Enhanced Epilepsy Treatment.Molecular neurobiology · 2026Review
- Redox-modulating metallic nanoparticles: mechanistic insights into pharmacological activity and cellular therapeutics.Naunyn-Schmiedeberg's archives of pharmacology · 2026Review
- Nanomedicine targeting neuroinflammatory pathways in Alzheimer's disease: a new frontier in inflammopharmacology.Inflammopharmacology · 2026Review
- Liposome-Mediated Bacterial Ferroptosis-like Death: A Novel Paradigm for Antimicrobial Therapy.Antibiotics (Basel, Switzerland) · 2026Review
- Magnetic Field-Guided Magnetic Nanoparticles as Neurotherapeutics for Neurological Disorders and Glioblastoma.Life (Basel, Switzerland) · 2026Review
- Emerging Approaches to Mitigate Neural Cell Degeneration with Nanoparticles-Enhanced Polyelectrolyte Systems.Membranes · 2025Review
- From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson's Disease Therapies.Biology · 2025Review
- Gold Nanoparticles Disrupt Mitochondrial Activity in Hypothalamic POMC Cells: Implications for Energy Homeostasis.Nanomaterials (Basel, Switzerland) · 2025Article
- Advancing Spinal Cord Injury Repair: The Role of Conductive Hydrogels in Neurotissue Engineering.International journal of nanomedicine · 2025Review
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metallic nanoparticles (NPs) possess unique physicochemical properties that have enabled their engineering for loading drugs, contrast agents, and targeting moieties for cellular and intracellular components, highlighting their emerging role as versatile tools in managing neurological disorders. In therapeutic applications, the surface plasmon resonance characteristics of gold and silver NPs and the responsiveness of magnetic nanoparticles (MNPs) to external magnetic fields facilitate the disruption of protein aggregates and the eradication of cancer cells. For diagnostic purposes, the inherent high electron density of metallic NPs makes them effective contrast agents in imaging technologies. Moreover, these NPs have proven their capability to traverse the blood-brain barrier (BBB) and interact with central nervous system (CNS) components. Despite their extensive scientific exploration and promising applications, metallic NPs have not yet achieved widespread clinical implementation, especially in comparison to polymer-based NPs. This article presents an in-depth examination of the physicochemical properties of metallic NPs relevant to neurological applications. It summarizes their roles in diagnosis and therapy, focusing on gold, magnetic, silver, titanium, and cerium NPs. Additionally, this document explains the incorporation of metal NPs in their application and their effect on the human body.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.